Citation Impact
Citing Papers
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
2006
The use of mRNA display to select high-affinity protein-binding peptides
2001 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity
2017
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
2017 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Mutual-information-based registration of medical images: a survey
2003 Standout
Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction
1993
Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage
1998 StandoutNobel
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
1997 StandoutNobel
The curative effect of a second curettage in persistent trophoblastic disease: A retrospective cohort survey
2005
Retargeting serum immunoglobulin with bispecific diabodies
1997 StandoutNobel
Antibody engineering and modification technologies
2007
Therapeutic cancer targeting peptides
2002
Prodrug Strategies in Anticancer Chemotherapy
2007
Gestational trophoblastic disease
2010 Standout
Designing and optimizing library selection strategies for generating high-affinity antibodies
1997
Disrupting tumour blood vessels
2005
Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy
2005
Comparative modeling of the N-terminal domain of the 67kDa laminin-binding protein: implications for putative ribosomal function
2003
Selective activation of anticancer prodrugs by monoclonal antibody–enzyme conjugates
2001
Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography
1995
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library
1996
Choriocarcinoma and partial hydatidiform moles
2000
Photodynamic therapy for cancer
2003 Standout
Specialization of tumour vasculature
2002
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study
2002
Antibody targeted drugs as cancer therapeutics
2006
Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer
2007
[5] Screening of phage antibody libraries
1996 StandoutNobel
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Antibody phage display technology and its applications
1998
Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia
2008
The biology of the combretastatins as tumour vascular targeting agents
2002
Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library
1996
Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?
1999
Calmodulin as a Versatile Tag for Antibody Fragments
1995 StandoutNobel
Vascular‐targeting therapies for treatment of malignant disease
2004
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Endothelial adhesion of synchronized gastric tumor cells changes during cell cycle transit and correlates with the expression level of CD44 splice variants
2005
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Expression of an antibody fragment at high levels in the bacterial cytoplasm
1998 StandoutNobel
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Enzyme immunoassays using bispecific diabodies
1997 StandoutNobel
Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [γ-32P]-ATP
1996 StandoutNobel
A prospective genetic study of complete and partial hydatidiform moles
1991
Mammalian cell–based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity
2005 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Complement recruitment using bispecific diabodies
1997 StandoutNobel
Biotechnological applications of phage and cell display
2001
A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage 1 1Edited by J. Karn
1999 StandoutNobel
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Towards the Design of an Antibody that Recognises a Given Protein Epitope
1999 StandoutNobel
Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
1999 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Ribosomal Protein Genes Are Overexpressed in Colorectal Cancer: Isolation of a cDNA Clone Encoding the Human S3 Ribosomal Protein
1991
Efficient Cancer Therapy with a Nanobody-Based Conjugate
2004
Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.
1999 StandoutNobel
RNA-peptide fusions for the in vitro selection of peptides and proteins
1997 StandoutNobel
Vascular Targeting Agents as Cancer Therapeutics
2004
Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
1995
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
2003
Functional mapping of disease susceptibility loci using cell biology
2006 StandoutNobel
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
2001
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
2002
Nanoparticles in Photodynamic Therapy
2015 Standout
Drug Discovery: A Historical Perspective
2000 StandoutScience
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Chimeric Antigen Receptor Therapy
2018 Standout
The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
2002
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein.
1991
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Antibody–Enzyme Fusion Proteins for Cancer Therapy
2011
Emerging Targets in Photopharmacology
2016 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Persistent trophoblast disease following partial molar pregnancy
2006
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Works of G Boxer being referenced
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents.
1996
Clinical Applications of Phage‐Derived sFvs and sFv Fusion Proteins
2000
Identification of a human ribosomal protein mRNA with increased expression in colorectal tumours
1989
Engineering Antibodies for Clinical Applications in Cancer
2004
Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole
1990
CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells
1993
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies
1994
A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology
1999
Phage libraries for generation of clinically useful antibodies
1994 StandoutNobel
A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti–Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug
2006
Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
2001
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.
1999
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.
2001
Mapping epitope characteristics on carcinoembryonic antigen
1986